Charcot-Marie-Tooth type 2B (CMT2B) disease is a dominant axonal peripheral neuropathy caused by 5 mutations in the RAB7A gene, a ubiquitously expressed GTPase controlling late endocytic trafficking. In neurons, RAB7A also controls neuronal-specific processes such as NTF (neurotrophin) trafficking and signaling, neurite outgrowth and neuronal migration. Given the involvement of macroautophagy/ autophagy in several neurodegenerative diseases and considering that RAB7A is fundamental for autophagosome maturation, we investigated whether CMT2B-causing mutants affect the ability of this gene to regulate autophagy. In HeLa cells, we observed a reduced localization of all CMT2B-causing RAB7A mutants on autophagic compartments. Furthermore, compared to expression of RAB7A WT , expression of these mutants caused a reduced autophagic flux, similar to what happens in cells expressing the dominant negative RAB7A T22N mutant. Consistently, both basal and starvation-induced autophagy were strongly inhibited in skin fibroblasts from a CMT2B patient carrying the RAB7A V162M mutation, suggesting that alteration of the autophagic flux could be responsible for neurodegeneration.
Introduction
More than 80 genes have been involved in Charcot-MarieTooth (CMT), a rare inherited peripheral neuropathy, and several of them are involved in the regulation of intracellular vesicular trafficking. 1, 2 The CMT type 2B (CMT2B) is a dominant axonal form caused by 5 mutations (L129F, K157N, N161T, V162M and the recently identified N161I) in the RAB7A gene, [3] [4] [5] [6] and it is characterized by prominent sensory loss, lower legs muscle atrophy, high frequency of foot ulcers and recurrent infections leading to toe amputations. [7] [8] [9] RAB7A, hereafter referred to as RAB7, is a ubiquitous small GTPase regulating late endocytic transport. [10] [11] [12] To investigate the role of RAB7 in the endocytic pathway, previous studies have used the dominant negative RAB7 T22N mutant, which displays reduced affinity for GTP and impaired nucleotide exchange, thus being mainly GDP-bound, and the constitutively active RAB7 Q67L mutant, which displays impaired intrinsic GTP hydrolysis, thus being mainly GTP-bound. 13 Others and we have demonstrated that CMT2B-causing RAB7 mutants show higher nucleotide K off , thus releasing nucleotides faster than expected and, consequently, displaying inhibited GTPase activity per binding event. [14] [15] [16] Indeed, given the higher K off for GDP compared to the wild-type protein and the higher concentration of GTP compared to GDP in cells, CMT2B mutant proteins are mostly in the GTP-bound form and, thus, were initially predicted to be active mutants.
14 However, given that K off for GTP is also increased compared to RAB7
WT , [14] [15] [16] thus determining early release of GTP, and that binding of GTP is not correctly regulated, 16 these mutants although being mainly GTP-bound and interacting more strongly with a number of effector proteins, 14, 16 could also display reduced efficiency in the activation of downstream specific effectors and pathways. In fact, studies on disease animal models established that in Drosophila, the presence of CMT2B mutant proteins induces sensory defects and dosage-dependent neurodegeneration due to partial loss of function, 17, 18 while in zebrafish axon growth and guidance defects are due to gain-offunction mechanisms. 19 Therefore, depending on the kinetic requirements of the processes controlled by RAB7, these mutants could behave as inhibitory or active.
RAB7 controls specific neuronal functions such as NTF (neurotrophin) trafficking and signaling and it is responsible for retrograde axonal traffic, neurite outgrowth and neuronal migration, [20] [21] [22] [23] [24] besides interacting with and regulating assembly of 2 intermediate filament proteins, VIM (vimentin) and PRPH (peripherin), which are involved in neurite outgrowth and axonal regeneration. [25] [26] [27] [28] [29] [30] [31] Neuronal functions are highly dependent on protein synthesis and degradation, and a constitutive autophagic flux is fundamental for a number of key neuronal processes. [32] [33] [34] Perturbation of the autophagic flux indeed causes neurodevelopmental and neurodegenerative diseases and has been observed, for instance, in Alzheimer disease, Parkinson disease and amyotrophic lateral sclerosis. 33, 34 Notably, RAB7 regulates autophagosomal maturation controlling the final step of maturation of late autophagic vesicles into autolysosomes, presumably involving fusion with lysosomes. 12, [35] [36] [37] In this manuscript we investigated the role of CMT2B-causing RAB7 mutant proteins in autophagy, demonstrating that expression of these mutants alters both basal and starvationinduced autophagy in HeLa cells. Furthermore, these finding were confirmed in patient skin fibroblasts carrying the RAB7 V162M mutation suggesting that neurodegeneration could be due to altered autophagy.
Results
To investigate the role of CMT2B-causing RAB7 mutant proteins (RAB7 L129F , RAB7 K157N , RAB7 N161T and RAB7 V162M ) on autophagy, we analyzed, by immunofluorescence analysis, colocalization of wild type and mutant proteins with the autopaghic vesicle marker LC3B. HeLa cells were analyzed after incubation in full medium to determine the basal level of RAB7 and LC3B colocalization, whereas starvation medium was used to induce the autophagic process, and bafilomycin A 1 (Baf), a drug inhibiting the vacuolar-type H + -translocating ATPase (VATPase), was used to prevent the lysosomal turnover of the autophagosome content (Fig. S1-S3 ). Consistent with previous results, 35 RAB7 WT displayed a good colocalization rate with LC3B, which increased upon starvation ( Fig. 1A; Fig. S1-S3 ). As expected, the constitutively active RAB7 Q67L mutant showed increased colocalization with LC3B both in full medium and in starvation medium ( Fig. 1A; Fig. S1-S2 ). Interestingly, CMT2B-causing mutants showed a reduced colocalization rate in each of the conditions tested, comparable with that of the dominant negative RAB7 T22N mutant ( Fig. 1A ; Fig. S1-S3 ), indicating that CMT2B-causing mutants are less recruited to autophagic vesicles when compared with RAB7 WT . Based on the established role of RAB7 in autophagy, 35 the reduced localization of this protein on autophagic vesicles suggests potential functional consequences of RAB7 mutant expression on this process.
Autophagosome number is one of the main mechanistic factors through which the amplitude of autophagic activity is regulated. 38 Therefore, we analyzed the number of autophagosomes in cells expressing RAB7
WT and mutant proteins. Interestingly, CMT2B-associated mutant proteins caused a reduction in the amount of autophagic vesicles in full medium, starvation medium and upon bafilomycin A 1 treatment, as compared to RAB7 WT (Fig. 1B) . The analysis of the autophagic flux, obtained by the ratio between the amount of autophagic vesicles in basal conditions (FM) and upon protease inhibition (Baf), 39 showed a reduced autophagic flux upon expression of the CMT2B-causing RAB7 mutants and, as expected, 35 of RAB7 T22N , as compared to RAB7
WT and RAB7 Q67L proteins (Fig. 1C ). To confirm these data, we also used a different approach, immunoblot analysis, in order to monitor the abundance of LC3B-II on extracts of HeLa cells transfected with empty vector or expressing RAB7
WT and mutant proteins and grown in full and starvation medium or treated with bafilomycin A 1 . As shown in Fig. 2A-C , we again observed a reduced autophagic flux upon expression of CMT2B-causing mutants as compared to the wild-type protein, with all mutant proteins behaving similarly to the dominant negative T22N form of RAB7 in full medium and upon bafilomycin A 1 treatment. It is worth noting that effects obtained with the RAB7 T22N mutant in immunofluorescence analysis are much stronger than the ones obtained by immunoblotting, as this mutant is generally less expressed and only with immunofluorescence can transfected cells be selected for analysis.
In order to further validate these data, we analyzed the autophagic flux also monitoring SQSTM1/p62 and GABARAP (Fig. 2 D-F) , 2 additional well established autophagy markers. 39 Data obtained using these markers confirmed that expression of the CMT2B-causing RAB7 mutant proteins reduced the autophagic flux compared to RAB7 WT . Interestingly, using these markers the expression of the constitutively active RAB7 Q67L increased the autophagic flux, whereas expression of the dominant negative RAB7 T22N caused a much stronger inhibition compared to the CMT2B-causing RAB7 mutant proteins, thus confirming the different nature of these mutants.
Altogether, these data strongly indicate that CMT2B-causing mutations negatively affect the role of RAB7 in the autophagic process.
In order to determine in which step the CMT2B-causing RAB7 mutant proteins inhibit autophagy, we used the tandem EGFP-mCherry-LC3B construct to monitor autophagic vesicle maturation (Fig. 3) . The basis for the utility of EGFP-mCherry-LC3B as a reporter for autophagic flux lies in the higher sensitivity of EGFP fluorescence to the acidic environment of the autolysosome relative to mCherry. Indeed, cells with higher flux have lower green signal due to the fusion of autophagosomes with lysosomes, which increases the mCherry:EGFP ratio in the cell. Using ratiometric flow cytometry, it is possible to calculate the flux in each cell based on this ratio. 40 Taking advantage of this method, we observed that, in CMT2B RAB7 mutants, autophagosomes had a reduced fusion rate to lysosomes as compared to RAB7
WT , while constitutive active RAB7 Q67L increased this rate and dominant negative RAB7 T22N strongly impaired it (Fig. 3) . In order to validate data obtained on transfected HeLa cells, we next isolated and cultured skin fibroblasts from a CMT2B patient carrying the RAB7 V162M mutation and from a healthy donor. 9 Again, we evaluated the colocalization rate between RAB7 and LC3B in control and CMT2B skin fibroblasts and observed a reduction of colocalization in CMT2B cells compared to control cells (»57%, »68% and »50% in full medium, starvation and upon bafilomycin A 1 treatment, respectively; Fig. 4A and B), consistent with data obtained in HeLa cells (Fig. 1A) .
Immunofluorescence analysis also revealed that the number of LC3B-positive vesicles was significantly reduced in CMT2B fibroblasts in each of the conditions tested and, in particular, the autophagic flux was significantly decreased in CMT2B fibroblasts (Fig. 4A , C and D). As a further confirmation, we also analyzed LC3B and RAB7 in fibroblasts by immunoblotting. In CMT2B cells, the autophagic flux was clearly reduced ( Fig. 5A and B) . Comparison of immunofluorescence and immunoblotting data showed that, while fewer LC3 vesicles were detected by immunofluorescence in CMT2B fibroblasts grown in full medium (Fig. 4A, C) , immunoblotting in the same conditions revealed an increase of LC3B-II ( Fig. 5A and  B) . However, it is worth noting that quantification of the autophagic flux in both cases demonstrated a strong inhibition (Fig. 4D, 5C ), and that differences detected in full medium could be due to the different antibodies employed and to the detection limits of fluorescence microscopy. The inhibition of the autophagic flux in CMT2B fibroblasts was also evident both by starving cells in the absence or presence of bafilomycin A 1 ( Fig. 5D-F) and by monitoring SQSTM1 and GABARAP-II after a long treatment with bafilomycin A 1 ( Fig. 5G-K) . Overall, our data, therefore, indicate a negative role of CMT2B mutations on autophagy while, at variance, the parallel endocytic pathway seems to be positively affected by the presence of the RAB7 V162M mutant as degradation of TFRC (transferrin receptor) is increased (Fig. S4) , confirming previous studies in different animal models (Drosophila, zebrafish) showing that CMT2B mutants could behave both as inhibitory and as active proteins, depending on the kinetic requirements of the processes controlled by RAB7 (see, also, the Introduction). [17] [18] [19] The role of RAB7 in autophagy has been extensively investigated and its function has been clearly correlated to autophagosome maturation and late endosome fusion with autophagic vesicles and lysosomes. 12, 41, 42 However, to verify that indeed CMT2B mutations in this gene do not affect also early phases of autophagosomal biogenesis, we evaluated the expression of the ATG12-ATG5 complex upon prolonged serum starvation. 38, 39, 43 Interestingly, ATG12-ATG5 levels similarly increased in normal and CMT2B fibroblasts, indicating that autophagosomal biogenesis was not affected by the RAB7 V162M mutation (Fig. 6A-C) . As an additional confirmation of this result, we also monitored the formation of ATG5 and ATG12 puncta in starved cells, which is another marker for autophagosomal biogenesis. 38, 39, [43] [44] [45] Indeed, normal and CMT2B fibroblasts showed a similar amount of ATG5 and ATG12 puncta per cell, both in full medium and in starved cells (Fig. 6D-G) , further supporting the idea that RAB7 V162M mutation does not affect autophagosomal biogenesis but acts in later steps of autophagosome maturation.
Discussion
Altogether, our results clearly indicate a reduction of CMT2B-causing RAB7 mutant localization on autophagic vesicles compared to the wild-type protein, suggesting functional consequences on autophagy, based on the important role of RAB7 in this process. 35, 42, [46] [47] [48] Indeed, by first using a HeLa model cell system, we demonstrate that, different from the wild-type protein, these mutants fail to increase the number of autophagosomes both in basal conditions and after stimulation, behaving similarly to the dominant negative and functionally impaired RAB7 T22N mutant. Still, while model cell lines are widely used as easily manageable tools to understand molecular mechanisms involved in a wide variety of cellular phenomena, they do not necessarily fully recapitulate the biological conditions of affected cells in vivo. Indeed, while cells of CMT2B-affected individuals have one wild-type and one mutated allele, HeLa cells encode 3 functional copies of RAB7, 49 thus probably reducing the overall effect of mutated RAB7 exogenous expression. Hence, the possibility to analyze CMT2B patient's skin fibroblasts, carrying the RAB7 V162M mutation together with only 1 wild-type allele, allowed us to obtain more convincing results, in the precise cellular conditions in which the disease develops. Importantly, as demonstrated in HeLa cells, also in CMT2B fibroblasts colocalization of the mutated RAB7 protein with LC3B was very limited (»20%) and the number of LC3B-positive organelles was strongly reduced compared to control fibroblasts, in all conditions, clearly demonstrating that, in affected cells, the autophagic flux is inhibited. Immunofluorescence data obtained in patients' cells were also confirmed by western blot analysis of LC3B, SQSTM1 and GABARAP demonstrating an inhibition of the autophagic flux. Overall, experiments with patients' fibroblasts confirmed and reinforced our HeLa cell data and supported a model in which specific mutations in the RAB7 proteins represent a strong limiting factor for basal and induced autophagy in affected individuals, suggesting a reduced ability of mutated cells to respond to intra-and extracellular stimuli through activation of autophagy. In this context, it is important to note that in CMT2B cells degradation of TFRC was increased compared to control cells (Fig. S4) , similar to what we previously observed for EGFR (epidermal growth factor receptor) by transiently overexpressing the mutant in HeLa cells, although data were not statistically significant probably because of transient transfection efficiency variations between experiments.
14 Therefore, the RAB7 V162M mutant seems to have a different impact on endocytosis and autophagy and these results confirm that, although endosomal and autophagosomal maturation processes share many machinery components, they also display important differences and thus can be differentially regulated. 50, 51 Clearly, further work is necessary to clarify the impact of CMT2B-causing mutant proteins on the endocytic pathway. Autophagy is an essential process to eliminate cellular waste and, in post-mitotic cells such as neurons, failure of this process may cause accumulation of protein aggregates and, ultimately, lead to cell damage. 52 Indeed, neurons have very high and efficient basal autophagic activity and altered autophagy is now recognized as an important cause of neuronal degeneration both in the central and peripheral nervous system. [52] [53] [54] [55] [56] Axons and dendrites are particularly sensitive to accumulation of protein aggregates or damaged organelles and a growing body of evidence indicates that altered (both increased or inhibited) autophagy can lead to axonal and/or dendrite degeneration. [57] [58] [59] [60] In addition, autophagy is induced after axonal damage in order to halt axonal degeneration. 61, 62 Therefore, the impaired ability of CMT2B-causing RAB7 mutant proteins to induce autophagy could limit this important neuroprotective mechanism and, in the long term, support the establishment of CMT2B disease.
In conclusion, our data indicate that CMT2B mutations strongly affect cellular autophagic flux and suggest that inhibition of autophagy caused by expression of altered RAB7 proteins could be the cause of increased axonal degeneration leading to the neuropathy. This information, therefore, suggests that the possibility of targeting autophagy may represent a potential approach to improve conditions of affected individuals, while taking advantage of assays for scoring autophagy (such as the described ratiometric flow cytometry flux assay) to rapidly evaluate, in vitro, the extent of the damage imposed by CMT2B-causing mutations and possibly select and guide forthcoming therapeutic options.
Materials and methods

Isolation of human fibroblasts
After informed consent for pathological diagnosis, residual tissue specimens were collected following a biobanking standard operating procedure. 63 The samples were anonymously encoded to protect patient confidentiality and used under protocols approved by the Azienda Ospedaliera Universitaria "Federico II" Ethics Committee (Ethical Committee Approval Protocol #107/05). Aliquots of fresh tissue specimens were minced in small fragments (less than 1 mm 3 ), in a sterile environment and processed to obtain primary cultures of mesenchymal cells, as previously reported. 64 Tissue digestion was carried out at 37 C, for 2-4 h in a solution of type IV collagenase, 1 mg/mL (Sigma-Aldrich, 10103586001), containing 40 mg/mL bovine serum albumin (Sigma-Aldrich, A7979), 2 mg/mL glucose (Sigma-Aldrich, G7021), 100 U/ml penicillin and 100 mg/ml streptomycin (Sigma-Aldrich, P0781), 50 mg/l gentamicin (Sigma-Aldrich, G1397), 1.25 mg/l of Fungizone (Gibco, 15240-062). The samples were then extensively rinsed with phosphate-buffered saline (PBS; Oxoid, BR0014G) and suspended in standard culture media supplemented with 10% fetal bovine serum (FBS; Gibco, 12763-025). After 3 cycles of centrifugation, cells were allowed to attach overnight in Dulbecco minimal essential medium (DMEM; Sigma-Aldrich, D6429), supplemented with 2 mM glutamine (Sigma-Aldrich, G7513), 100 U/ml penicillin and 100 mg/ml streptomycin, 15 mM HEPES (Sigma-Aldrich, H0887), 20% fetal bovine serum. Cells were cultured in 6-well plates at 37 C in a humidified atmosphere of 5% CO 2 . The medium was renewed twice weekly.
Patient and control individual
Skin fibroblasts were obtained from the patient III.7 of the first identified Italian family affected by CMT2B, a 46-year old man, whose clinical history and symptoms have been already described. 9 Cells were also obtained from a healthy control individual age and sex matched.
Cells and culture conditions
Normal dermal human fibroblasts and dermal fibroblasts derived from a CMT2B patient were maintained in DMEM (Euroclone, ECB7501L) supplemented with 20% FBS (Euroclone, EUS0180L), 2 mM L-glutamine (Euroclone, ECB3000D), 100 units/ml penicillin-streptomycin (Euroclone, ECB3001D) at 37 C in an atmosphere of 5% CO 2 :air. HeLa cells were maintained as previously described. 65 Briefly, they were cultured in DMEM as just described, except that 10% FBS was used. For immunofluorescence experiments cells were seeded on coverslips placed in 12-well plates; 5 £ 10 4 HeLa cells and 5 £ 10 3 fibroblasts were seeded in each well. For western blot and cytofluorometric analysis, 2 £ 10 5 HeLa cells were seeded in 6-well plates and 3 £ 10 5 fibroblast cells were seeded in 10-cm dishes. HeLa cells were transfected using Lipofectamine LTX (Life Technologies, 15338500) with the indicated plasmids (500 ng for 12-well and 1000 ng for 6-well) 24 h before harvesting for western blot analysis and 48 h before fixing for immunofluorescence. 66 
Plasmids
Plasmids encoding HA-tagged RAB7
WT and the dominant negative RAB7 T22N , the constitutively active RAB7 Q67L and the CMT2B-causing RAB7 L129F , RAB7 K157N , RAB7 N161T , and RAB7 V162M mutant proteins, have been previously described.
14,15 The pcDNA3-HA plasmid was constructed by inserting a DNA sequence coding for a 2xHA-tag into the KpnI restriction site of the pCDNA3.1 (Invitrogen, V79020) and it was used as empty vector in control transfections. pBABE-puro mCherry-EGFP-LC3B was a gift from Jayanta Debnath (Addgene, 22418). 67 
Reagents and antibodies
Bafilomycin A 1 (Santa Cruz Biotechnology, sc-201550) was dissolved in DMSO. Hanks medium (ECB4006L), used as starvation medium, was obtained from Euroclone. For western blot analysis the following primary antibodies were used: anti-RAB7 (Santa Cruz Biotechnology, sc-376362), anti-HA (Covance, MMS-101R), anti-LC3B (Nanotools, 0231-1000), anti-GABARAP (MBL, M135-3), anti-SQSTM1/p62 (BD Biosciences, 610833), anti-tubulin/TUBA1A (Sigma-Aldrich, T5168) and anti-MAPK1/ERK2 (Santa Cruz Biotechnology, sc-154). rabbit Alexa Fluor 555-conjugated (Life Technologies, A31572), and anti-rat Alexa Fluor 594-conjugated (Life Technologies, A21209).
Western blot analysis
Total lysates were obtained and treated as previously described. 68 Briefly, washed cellular pellet fractions were resuspended in MAPK lysis buffer made of 20 mM HEPES (PAA, S11001), pH 7.5, 10 mM EGTA (Sigma-Aldrich, E4378), 40 mM beta-glycerophosphate (Sigma-Aldrich, G6501), 1% NP-40 (Sigma-Aldrich, I3021), 2.5 mM MgCl 2 (Sigma-Aldrich, M2670), 2 mM orthovanadate (Sigma-Aldrich, S6508), 2 mM NaF (Carlo Erba, 7681494), 1 mM DTT (IBI, IB21040), Roche protease inhibitors cocktail (Roche Diagnostics, 05056489001). Proteins were quantified by the Bradford assay and, before loading, 5X Laemmli sample buffer was added to the lysates, which were next incubated for 5 min at 95 C. Alternatively cells were directly lysed in 1X Laemmli. Lysates were loaded on SDS-PAGE polyacrylamide gels, transferred to Immobilon-P PVDF membrane (Millipore, IPVH00010), probed with the appropriate antibodies, and detected using enhanced chemoluminescence (ECL Prime; GE Healthcare, RPN2232). Images were then acquired with a LAS 4000 imager (GE Healthcare, Italy, Milan). Densitometric analysis of western blots was performed with NIH ImageJ 1.43u (National Institutes of Health).
Immunofluorescence
Cells were cultured and treated as previously described. 65 Briefly, they were washed with PBS, then fixed with 4% paraformaldehyde (Sigma-Aldrich, 47608) in 1X PBS for 20 min and permeabilized with 0.2% Triton X-100 (Sigma-Aldrich, T8787) for 10 min or 100 mg/ml digitonin solution (Life Technologies, BN2006) for 20 min. Permeabilized cells were incubated with the appropriate primary antibodies for 1 h, washed 3 times with 1X PBS, incubated for 30 min with appropriate secondary antibodies and then washed again 3 times in 1X PBS. Nuclei were stained with a solution of 1.5 mM of 4',6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich, D9542) in PBS for 5 min. Coverslips were mounted in Fluorescence Mounting Medium (Dako, S3023). Samples were visualized on a TSC SP5 confocal microscope (Leica Microsystems, Germany, Mannheim) installed on an inverted LEICA DMI 6000CS microscope (Leica Microsystems, Germany, Mannheim) and equipped with an oil immersion PlanApo 63 £ 1.4 NA objective. Images were acquired using the LAS AF acquisition software (Leica Microsystems).
Flow cytometry
Cells treated with full medium or starvation medium were harvested and resuspended in the same medium of the treatment for FACS analysis to avoid autophagic flux changes. EGFP and mCherry fluorescence signal were evaluated by flow cytometry in LSR-II FACS (BD Biosciences, Italy, Milan), equipped with 488-nm and 561-nm laser according to Gump and Thorburn. 40 A derived parameter with the ratio between mCherry and EGFP signal was generated to measure the autophagic flux. For each sample at least 5 £ 10 5 cells were acquired for each experiment.
Dot count and colocalization rate
For the LC3B-positive dot count, we performed intensitometric analysis of fluorescence using the Quantitation Module of Volocity software (PerkinElmer Life Science).
69 LC3B dots area, Pearson correlation and colocalization rate were also measured by the Quantitation Module of Volocity software. Dot count and colocalization rate were subjected to statistical analysis. Measures were obtained by analyzing at least 400 cells/sample for at least 3 different experiments. Significance (P value) was assessed by one-way ANOVA test.
TFRC degradation
Cells were incubated with 50 mg/ml cycloheximide (SigmaAldrich, C7698) up to 8 h and then lysed. Lysates were subjected to western blot analysis with anti-TFRC/transferrin receptor antibody (mouse monoclonal G1/221/12 developed by H.P. Hauri and obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA, USA) to follow TFRC degradation. 
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